These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24261894)

  • 1. Flavaglines: potent anticancer drugs that target prohibitins and the helicase eIF4A.
    Basmadjian C; Thuaud F; Ribeiro N; Désaubry L
    Future Med Chem; 2013 Dec; 5(18):2185-97. PubMed ID: 24261894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses.
    Nebigil CG; Moog C; Vagner S; Benkirane-Jessel N; Smith DR; Désaubry L
    Eur J Med Chem; 2020 Oct; 203():112653. PubMed ID: 32693294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1-Aminomethyl SAR in a novel series of flavagline-inspired eIF4A inhibitors: Effects of amine substitution on cell potency and in vitro PK properties.
    Nilewski C; Michels TD; Packard GK; Xiang AX; Sprengeler PA; Eam B; Fish S; Thompson PA; Wegerski CJ; Nevarez A; Clarine J; Sperry S; Ernst JT; Reich SH
    Bioorg Med Chem Lett; 2021 Sep; 47():128111. PubMed ID: 34353608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative phytochemistry of flavaglines (= rocaglamides), a group of highly bioactive flavolignans from
    Greger H
    Phytochem Rev; 2022; 21(3):725-764. PubMed ID: 34104125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ATP-competitive, marine derived natural products that target the DEAD box helicase, eIF4A.
    Tillotson J; Kedzior M; Guimarães L; Ross AB; Peters TL; Ambrose AJ; Schmidlin CJ; Zhang DD; Costa-Lotufo LV; Rodríguez AD; Schatz JH; Chapman E
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4082-4085. PubMed ID: 28757063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of the DEAD-box RNA helicase eukaryotic initiation factor (eIF) 4A by natural products.
    Shen L; Pelletier J
    Nat Prod Rep; 2020 May; 37(5):609-616. PubMed ID: 31782447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavaglines as potent anticancer and cytoprotective agents.
    Ribeiro N; Thuaud F; Bernard Y; Gaiddon C; Cresteil T; Hild A; Hirsch EC; Michel PP; Nebigil CG; Désaubry L
    J Med Chem; 2012 Nov; 55(22):10064-73. PubMed ID: 23072299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of eukaryotic translation initiation by the marine natural product pateamine A.
    Low WK; Dang Y; Schneider-Poetsch T; Shi Z; Choi NS; Merrick WC; Romo D; Liu JO
    Mol Cell; 2005 Dec; 20(5):709-22. PubMed ID: 16337595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoxazoline containing natural products as anticancer agents: a review.
    Kaur K; Kumar V; Sharma AK; Gupta GK
    Eur J Med Chem; 2014 Apr; 77():121-33. PubMed ID: 24631731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 3,3'-pyrrolidinyl-spirooxindoles as cardioprotectant prohibitin ligands.
    Elderwish S; Audebrand A; Nebigil CG; Désaubry L
    Eur J Med Chem; 2020 Jan; 186():111859. PubMed ID: 31735574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyrazole containing natural products: synthetic preview and biological significance.
    Kumar V; Kaur K; Gupta GK; Sharma AK
    Eur J Med Chem; 2013 Nov; 69():735-53. PubMed ID: 24099993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stopping trouble before it starts.
    Clardy J
    ACS Chem Biol; 2006 Feb; 1(1):17-9. PubMed ID: 17163634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simplified silvestrol analogues with potent cytotoxic activity.
    Hawkins BC; Lindqvist LM; Nhu D; Sharp PP; Segal D; Powell AK; Campbell M; Ryan E; Chambers JM; White JM; Rizzacasa MA; Lessene G; Huang DC; Burns CJ
    ChemMedChem; 2014 Jul; 9(7):1556-66. PubMed ID: 24677741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RNA-mediated sequestration of the RNA helicase eIF4A by Pateamine A inhibits translation initiation.
    Bordeleau ME; Cencic R; Lindqvist L; Oberer M; Northcote P; Wagner G; Pelletier J
    Chem Biol; 2006 Dec; 13(12):1287-95. PubMed ID: 17185224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular mechanisms and anti-cancer aspects of the medicinal phytochemicals rocaglamides (=flavaglines).
    Li-Weber M
    Int J Cancer; 2015 Oct; 137(8):1791-9. PubMed ID: 24895251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitumor activity of cyclodepsipeptide zygosporamide and its analogues.
    Wang Y; Zhang F; Zhang Y; Liu JO; Ma D
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4385-7. PubMed ID: 18606540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural glycoconjugates with antitumor activity.
    La Ferla B; Airoldi C; Zona C; Orsato A; Cardona F; Merlo S; Sironi E; D'Orazio G; Nicotra F
    Nat Prod Rep; 2011 Mar; 28(3):630-48. PubMed ID: 21120227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and SAR studies of marine natural products ma'edamines A, B and their analogues.
    Saha S; Reddy ChV; Xu S; Sankar S; Neamati N; Patro B
    Bioorg Med Chem Lett; 2013 Sep; 23(18):5135-9. PubMed ID: 23927972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on Phytochemical and Biological Studies on Rocaglate Derivatives from Aglaia Species.
    Agarwal G; Chang LS; Soejarto DD; Kinghorn AD
    Planta Med; 2021 Oct; 87(12-13):937-948. PubMed ID: 33784769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.